Link to report below.
Investors, analysts and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session at
The presentation can be followed live or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call.
To participate in the conference call, please call:
US: +1 631 913 14 22 (toll) PIN: 50558397#
Sobi
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Providing sustainable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,600 employees across
Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.
Postal address SE-112 76
Phone: 46 8 697 20 00 www.sobi.com
https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-publishes-q4-and-fy-2021-report,c3502128
https://mb.cision.com/Main/14266/3502128/1532316.pdf
(c) 2022 Cision. All rights reserved., source